Autologous iPSC-derived retinal pigment epithelium transplantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous iPSC-derived retinal pigment epithelium transplantation, covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration [Phase 1, Phase 2]